Douglas Grossman,
MD, PhD
Languages Spoken: English
Labs: Website
Douglas Grossman, MD, PhD, is an investigator in Huntsman Cancer Institute's (HCI) Melanoma Program and a Professor in the Department of Dermatology at the University of Utah School of Medicine. He is Co-Leader of the Melanoma center at HCI. He sees patients at risk for melanoma and non-melanoma skin cancer, with a special interest in patients who have a personal or family history of melanoma; numerous and/or atypical moles (nevi); a personal history of basal or squamous cell carcinoma; or a history of excessive sun exposure. Grossman had directed the Mole Mapping Program at HCI since 2004.
Grossman's lab studies mechanisms of tumor development and metastasis in melanoma. In addition, they study the role of UV-induced oxidative stress and DNA damage using human nevi (moles) as a model system. They are using this knowledge to develop novel chemopreventive agents for patients at increased risk for melanoma.
Grossman received his MD and PhD from Baylor College of Medicine, completed an internship at Yale-New Haven Hospital, and completed a dermatology residency at Yale. He remained at Yale for a research fellowship in cancer biology, and then joined Huntsman Cancer Institute and the University of Utah School of Medicine faculty in 2001.
Douglas Grossman, MD, PhD, is an expert in the early diagnosis and treatment of skin cancers. He received his medical degree from Baylor College of Medicine in 1994, and completed his dermatology training at Yale University School of Medicine in 1998. Following a research fellowship in cancer biology at Yale, he was recruited to the University of Utah in 2001. He sees patients with a personal history of skin cancer or excessive sun exposure, and those at increased risk for melanoma who may have numerous or atypical moles or family members with melanoma. He directs the Mole Mapping Program at the Huntsman Cancer Institute.
Clinical Locations
801-581-2955
Board Certification and Academic Information
| Academic Departments | Dermatology
-
Professor Oncological Sciences - Adjunct Professor |
| Board Certification | American Board of Dermatology (Dermatology) |
Patient Rating
The Patient Rating score is an average of all responses to care provider related questions on our nationally-recognized Press Ganey Patient Satisfaction Survey.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
Likelihood of recommending care provider
4.8/ 5
Care provider's explanation of condition/problem
4.9/ 5
Care provider's effort to include me in decisions
4.8/ 5
Wait time at clinic
4.7/ 5
Care provider's concern for questions & worries
4.8/ 5
Patient Comments
Patient comments are gathered from our Press Ganey Patient Satisfaction Survery and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.
UofU Patient
May 20, 2021
HUNTSMAN CANCER CENTER
He is confident and is smart and tries very hard to give a person confidence as to a cure, we'll see.
UofU Patient
May 18, 2021
HUNTSMAN CANCER CENTER
Explained throughout our whole conversation about what we might do!
UofU Patient
May 17, 2021
HUNTSMAN CANCER CENTER
dr grossman always tells me exactly what he is doing and what the outcomes could be. he answers every question. he take my call to him on his personal phone and fits me into his otherwise full schedule when I need immediate attention.
UofU Patient
May 15, 2021
HUNTSMAN CANCER CENTER
Great visit. Dr. Grossman is the best.
UofU Patient
May 10, 2021
HUNTSMAN CANCER CENTER
Honestly I was terrified of this appointment, but Dr. Grossman and his tech Ryan were very nice, informative, thorough, and patient with me even when I had some gaps in my medical history due to me being very young when my original diagnosis was made. They did a great job of explaining the process, taking any concerns I had into consideration, Dr. Grossman gave his full assessment and recommendations in a way that made it easy for me to understand what to expect in the future with upcoming visits. I also really appreciated to extra education on mineral based sunscreen as I have never had prevention measures discussed with me before by any other provider, an was not even aware of the benefits. All in all this was a great experience and I left feeling confident about the plan, and at ease about every concern I had going into the visit. One other care provider whose name I cannot remember was the sweetest lady who took my pictures for the mole mapping. She had blonde hair, and likes to run with her doggy. I wish I could remember what her name was, but she was also absolutely amazing. I can't thank her enough for easing the awkwardness of standing in front of a stranger in your underwear by making great conversation and also by giving a thorough explanation of each step of the mole mapping process.
UofU Patient
May 06, 2021
HUNTSMAN CANCER CENTER
He was thorough, very smart and he called me today to explain his plan in detail, as a RN I would give him an A+ for taking the time to do it himself!
UofU Patient
April 27, 2021
HUNTSMAN CANCER CENTER
Very concerned Dr Grossman. Love working with him. He is a very good Doctor
UofU Patient
April 18, 2021
HUNTSMAN CANCER CENTER
great staff
UofU Patient
April 08, 2021
HUNTSMAN CANCER CENTER
good
UofU Patient
April 07, 2021
HUNTSMAN CANCER CENTER
nothing to describe..other than relaxed and easy
UofU Patient
April 02, 2021
HUNTSMAN CANCER CENTER
Dr Grossman is always attentive, through, and professional. Knowledgeable and alert.
UofU Patient
April 02, 2021
HUNTSMAN CANCER CENTER
all good
UofU Patient
March 30, 2021
HUNTSMAN CANCER CENTER
I feel like Dr. Grossmann glossed over my concerns and did not do a thorough inspection.
UofU Patient
March 23, 2021
HUNTSMAN CANCER CENTER
I do not know how it could be improved or made better
UofU Patient
March 22, 2021
HUNTSMAN CANCER CENTER
Dr. Grossman is the best.
UofU Patient
March 21, 2021
HUNTSMAN CANCER CENTER
Dr Grossman is always very concerned about my health and also my personal scheduling needs since I drive a long distance to see him. He is very worth the long drive. I wouldn't change doctors.
UofU Patient
March 18, 2021
HUNTSMAN CANCER CENTER
Excellent, as always
UofU Patient
March 18, 2021
HUNTSMAN CANCER CENTER
The doctor is always very through and explained everything.
UofU Patient
March 15, 2021
HUNTSMAN CANCER CENTER
Dr Grossman was very thorough and friendly.
UofU Patient
March 15, 2021
HUNTSMAN CANCER CENTER
Dr. Grossman is wonderful!
UofU Patient
March 12, 2021
HUNTSMAN CANCER CENTER
the entire clinic is always excellent, I have been a patient there for almost twenty years and have ALWAYS had a good experience,. the efficiency of the clinic is very important to me, nobody wants to wait around for hours!
UofU Patient
March 10, 2021
HUNTSMAN CANCER CENTER
excellent treatment, concern and competence
UofU Patient
February 27, 2021
HUNTSMAN CANCER CENTER
For my sun exposure especially during my youth and my sister's multiple melanoma diagnoses, Dr Grossman has the ideal expertise for my potential for skin cancer. So far, I've been fortunate to have had only minor issues (age 71). I feel in excellent hands. He is thorough, cordial and professional.
UofU Patient
February 12, 2021
HUNTSMAN CANCER CENTER
very informative
UofU Patient
February 08, 2021
HUNTSMAN CANCER CENTER
Already have referred someone to Dr. Grossman.
UofU Patient
February 03, 2021
HUNTSMAN CANCER CENTER
During my check up the Doctor found a spot he wanted to biopsy and was very good at explaining the reason and what would possibly happen after the sample was examined by the lab.
UofU Patient
January 18, 2021
HUNTSMAN CANCER CENTER
doctor was attentive and answered concerns with easily understood information regarding treatment
UofU Patient
January 18, 2021
HUNTSMAN CANCER CENTER
I have many options much closer to where I live (about 45 min drive). I choose dr grossman
UofU Patient
January 08, 2021
HUNTSMAN CANCER CENTER
Regarding this visit, my first impressions of this doctor remain in limbo. He seems extremely knowledgeable about dermatology, mole mapping, melanoma and other skin cancers. However, I would encourage watching or re-watching "Empathy: The Human Connection to Patient Care" from the Cleveland Clinic regarding the importance of empathy towards cancer patients. I would not discourage anyone from making an appointment with this provider, just be prepared to not have your primary concerns heard or taken seriously. Perhaps he was having a hard day-he's human too; I can understand that and would sincerely give him another chance. Unfortunately, I did leave feeling like I needed to make an appointment with another doctor to find out why I haven't been feeling well lately. Hopefully, when I see Dr. Grossman again in a few months, things will go better for both of us.
UofU Patient
January 07, 2021
HUNTSMAN CANCER CENTER
Have referred several patients to Dr. Doug Grossman.
UofU Patient
December 14, 2020
HUNTSMAN CANCER CENTER
Best experience ever! Dr Grossman gave me a thorough exam all the while allowing me to be modest. He was very friendly and informative and knowledgeable about my health issues.
UofU Patient
December 04, 2020
HUNTSMAN CANCER CENTER
everything was great
UofU Patient
November 27, 2020
HUNTSMAN CANCER CENTER
very good
UofU Patient
November 23, 2020
HUNTSMAN CANCER CENTER
Excellent
UofU Patient
November 20, 2020
HUNTSMAN CANCER CENTER
Dr. Grossman would ask me a question, and before I could finish my response, he would be next to the nurse telling them what to type into my chart. I appreciate the thoroughness of his documenting my case, but more than once I had to return to what I was saying to make sure that he had heard & understood what I was trying to tell him.
UofU Patient
October 27, 2020
HUNTSMAN CANCER CENTER
This is a top notch doctor and staff
UofU Patient
October 25, 2020
HUNTSMAN CANCER CENTER
fantastic
UofU Patient
September 27, 2020
HUNTSMAN CANCER CENTER
I like Dr. G. and think he's highly competent, but he's very self assured and sometimes interrupts me before I'm finished saying what I wanted to say (and I'm not quite sure that he has really listened because he thinks he knows what I'm asking or saying, but sometimes he doesn't quite get my concern right).
UofU Patient
August 27, 2020
HUNTSMAN CANCER CENTER
It felt a bit rushed and unimportant with Dr. Grossman. He is a very knowledgeable person but seems to have a hard time coming down to the patient's level and expressing care/concern.
UofU Patient
August 25, 2020
HUNTSMAN CANCER CENTER
Dr Grossman always gives great care.
UofU Patient
August 20, 2020
HUNTSMAN CANCER CENTER
efficient appointment - Dr. quickly referenced prior records, solicited any concerns I may have, completed check-up, closed with making sure I was knowledgable as to how to make an appointment or contact in the future if necessary. Polite inquiry regarding a student participating in the appointment by both nurse and doctor as well.
UofU Patient
August 20, 2020
HUNTSMAN CANCER CENTER
Dr. Grossman is very professional and explains every very well. Always takes the time to answer my questions.
UofU Patient
August 18, 2020
HUNTSMAN CANCER CENTER
excellent
UofU Patient
August 03, 2020
HUNTSMAN CANCER CENTER
Dr. Grossman is a gem.
UofU Patient
August 01, 2020
HUNTSMAN CANCER CENTER
Dr Grossman, supported by his team, was wholly focused on me and my care. The overview and updates as the procedure progressed were timely and easy to understand
UofU Patient
August 01, 2020
HUNTSMAN CANCER CENTER
Dr. Douglas Grossman was very busy, behind schedule, but did a thorough job of doing the mole mapping review with the most recent disc and checking my whole body over for anything that was a concern either to him or myself. He found nothing and answered all my questions to my satisfaction.
UofU Patient
August 01, 2020
HUNTSMAN CANCER CENTER
excellent doctor
UofU Patient
July 22, 2020
HUNTSMAN CANCER CENTER
Dr Grossman and his team were as usual, very professional, through, and attentive.
UofU Patient
July 20, 2020
HUNTSMAN CANCER CENTER
Dr. Grossman is simply outstanding.
UofU Patient
July 11, 2020
HUNTSMAN CANCER CENTER
excellent
Douglas Grossman, MD, PhD, is an investigator in Huntsman Cancer Institute's (HCI) Melanoma Program and a Professor in the Department of Dermatology at the University of Utah School of Medicine. He is Co-Leader of the Melanoma center at HCI. He sees patients at risk for melanoma and non-melanoma skin cancer, with a special interest in patients who have a personal or family history of melanoma; numerous and/or atypical moles (nevi); a personal history of basal or squamous cell carcinoma; or a history of excessive sun exposure. Grossman had directed the Mole Mapping Program at HCI since 2004.
Grossman's lab studies mechanisms of tumor development and metastasis in melanoma. In addition, they study the role of UV-induced oxidative stress and DNA damage using human nevi (moles) as a model system. They are using this knowledge to develop novel chemopreventive agents for patients at increased risk for melanoma.
Grossman received his MD and PhD from Baylor College of Medicine, completed an internship at Yale-New Haven Hospital, and completed a dermatology residency at Yale. He remained at Yale for a research fellowship in cancer biology, and then joined Huntsman Cancer Institute and the University of Utah School of Medicine faculty in 2001.
Douglas Grossman, MD, PhD, is an expert in the early diagnosis and treatment of skin cancers. He received his medical degree from Baylor College of Medicine in 1994, and completed his dermatology training at Yale University School of Medicine in 1998. Following a research fellowship in cancer biology at Yale, he was recruited to the University of Utah in 2001. He sees patients with a personal history of skin cancer or excessive sun exposure, and those at increased risk for melanoma who may have numerous or atypical moles or family members with melanoma. He directs the Mole Mapping Program at the Huntsman Cancer Institute.
Academic Locations
Huntsman Cancer Hospital
801-581-4682
Board Certification and Academic Information
| Academic Departments | Dermatology
-
Professor Oncological Sciences - Adjunct Professor |
| Board Certification | American Board of Dermatology (Dermatology) |
Research Interests
- Melanoma
- Moles
- p16 Tumor Suppressor
- Survivin
- Metastasis
- Oxidative Stress
- Chemoprevention
Education History
| Fellowship | Yale University School of Medicine Laboratory of Dario C. Altieri, M.D. Fellow |
| Residency | Yale University School of Medicine Dermatology Resident |
| Internship | Yale New Haven Hospital Internal Medicine Intern |
| Professional Medical | Baylor College of Medicine Medicine M.D. |
| Doctoral Training | Baylor College of Medicine Immunology; Laboratory of Robert R. Rich, M.D Ph.D. |
| Undergraduate | Duke University Chemistry B.S. |
Selected Publications - Journal Articles
Journal Article
- Haynes D, Strunck JL, Said J, Tam I, Varedi A, Topham CA, Olamiju B, Wei BM, Erickson MK, Wang LL, Tan A, Stoner R, Hartman RI, Lilly E, Grossman D, Curtis JA, Westerdahl JS, Leventhal JS, Choi JN, Chu EY, Ming ME, Stein JA, Liebman TN, Berry E, Greiling TM (2020). Association between halo nevi and melanoma in adults: A multicenter retrospective case series. J Am Acad Dermatol, 84(4), 1164-1166.
- Nagelhout ES, Lensink R, Zhu A, Parsons BG, Haaland B, Hashibe M, Grossman D, VanDerslice J, Gren LH, Jensen JD, Wu YP (2022). Higher Ultraviolet Radiation Exposure Among Rural-Dwelling Versus Urban-Dwelling Adults and Children: Implications for Skin Cancer Prevention. J Community Health, 46(1), 147-155.
- Atkins MB, Curiel-Lewandrowski C, Fisher DE, Swetter SM, Tsao H, Aguirre-Ghiso JA, Soengas MS, Weeraratna AT, Flaherty KT, Herlyn M, Sosman JA, Tawbi HA, Pavlick AC, Cassidy PB, Chandra S, Chapman PB, Daud A, Eroglu Z, Ferris LK, Fox BA, Gershenwald JE, Gibney GT, Grossman D, Hanks BA, Hanniford D, Hernando E, Jeter JM, Johnson DB, Khleif SN, Kirkwood JM, Leachman SA, Mays D, Nelson KC, Sondak VK, Sullivan RJ, Merlino G, Melanoma Research Foundation (2021). The State of Melanoma: Emergent Challenges and Opportunities. (Epub ahead of print) Clin Cancer Res.
- Flint ND, Bishop MD, Smart TC, Strunck JL, Boucher KM, Grossman D, Secrest AM (2020). Low accuracy of self-reported family history of melanoma in high-risk patients. Fam Cancer, 20(1), 41-48.
- Rahman H, Kumar D, Liu T, Okwundu N, Lum D, Florell SR, Burd CE, Boucher KM, VanBrocklin MW, Grossman D (2020). Aspirin Protects Melanocytes and Keratinocytes against UVB-Induced DNA Damage In Vivo. J Invest Dermatol, 141(1), 132-141.e3.
- Hawryluk EB, Moustafa D, Bartenstein D, Brahmbhatt M, Cordoro K, Gardner L, Gauthier A, Grossman D, Gupta D, Hunt RD, Jen M, Kao PC, Kruse LL, Lawley LP, London WB, Mansour D, OHaver JA, Phung T, Pope E, Price HN, Rogers T, Shah SD, Wolner Z, Huang J, Marghoob AA (2020). A retrospective multicenter study of fatal pediatric melanoma. J Am Acad Dermatol, 83(5), 1274-1281.
- Grossman D, Okwundu N, Bartlett EK, Marchetti MA, Othus M, Coit DG, Hartman RI, Leachman SA, Berry EG, Korde L, Lee SJ, Bar-Eli M, Berwick M, Bowles T, Buchbinder EI, Burton EM, Chu EY, Curiel-Lewandrowski C, Curtis JA, Daud A, Deacon DC, Ferris LK, Gershenwald JE, Grossmann KF, Hu-Lieskovan S, Hyngstrom J, Jeter JM, Judson-Torres RL, Kendra KL, Kim CC, Kirkwood JM, Lawson DH, Leming PD, Long GV, Marghoob AA, Mehnert JM, Ming ME, Nelson KC, Polsky D, Scolyer RA, Smith EA, Sondak VK, Stark MS, Stein JA, Thompson JA, Thompson JF, Venna SS, Wei ML, Swetter SM (2020). Prognostic Gene Expression Profiling in Cutaneous Melanoma: Identifying the Knowledge Gaps and Assessing the Clinical Benefit. JAMA Dermatol, 156(9), 1004-1011.
- Parsons BG, Hay JL, Aspinwall LG, Zaugg K, Zhu A, Mooney RH, Klein SZ, Grossman D, Leachman SA, Wu YP (2021). Understanding Skin Screening Practices Among Children at Elevated Risk for Melanoma to Inform Interventions for Melanoma Prevention and Control. J Cancer Educ, 35(3), 509-514.
- Li C, Liu T, Tavtigian SV, Boucher K, Kohlmann W, Cannon-Albright L, Grossman D (2019). Targeted germline sequencing of patients with three or more primary melanomas reveals high rate of pathogenic variants. Melanoma Res, 30(3), 247-251.
- Truong A, Hyngstrom JR, Andtbacka RHI, Noyes RD, Wright M, Snyder J, Winters A, Sause WT, Grossmann KF, Khong HT, Bowen GM, Hitchcock YJ, Grossman D, Bowles TL (2019). Recurrence risk of early-stage melanoma of the external ear: an investigation of surgical approach and sentinel lymph node status. Melanoma Res, 30(2), 173-178.
- Jensen JD, Pokharel M, King AJ, John KK, Wu YP, Grossman D (2019). Obstacles to skin self-examination: are frontier adults inclined abstainers? Psychology, Health & Medicine, 25(4), 470-479.
- Strunck JL, Smart TC, Boucher KM, Secrest AM, Grossman D (2020). Improved melanoma outcomes and survival in patients monitored by total body photography: A natural experiment. J Dermatol, 47(4), 342-347.
- Varedi A, Rahman H, Kumar D, Catrow JL, Cox JE, Liu T, Florell SR, Boucher KM, Okwundu N, Burnett WJ, VanBrocklin MW, Grossman D (2020). ASA Suppresses PGE2 in Plasma and Melanocytic Nevi of Human Subjects at Increased Risk for Melanoma. Pharmaceuticals (Basel), 13(1).
- Wu YP, Boucher K, Hu N, Hay J, Kohlmann W, Aspinwall LG, Bowen DJ, Parsons BG, Nagelhout ES, Grossman D, Mooney K, Leachman SA, Tercyak KP (2019). A pilot study of a telehealth family-focused melanoma preventive intervention for children with a family history of melanoma. Psychooncology, 29(1), 148-155.
- Nagelhout ES, Parsons BG, Haaland B, Tercyak KP, Zaugg K, Zhu A, Harding G, Yancey J, Jensen JD, Grossman D, Wetter DW, Wu YP (2019). Differences in reported sun protection practices, skin cancer knowledge, and perceived risk for skin cancer between rural and urban high school students. Cancer Causes Control, 30(11), 1251-1258.
- Marsh RA, Leiding JW, Logan BR, Griffith LM, Arnold DE, Haddad E, Falcone EL, Yin Z, Patel K, Arbuckle E, Bleesing JJ, Sullivan KE, Heimall J, Burroughs LM, Skoda-Smith S, Chandrakasan S, Yu LC, Oshrine BR, Cuvelier GDE, Thakar MS, Chen K, Teira P, Shenoy S, Phelan R, Forbes LR, Chellapandian D, Dvila Saldaa BJ, Shah AJ, Weinacht KG, Joshi A, Boulad F, Quigg TC, Dvorak CC, Grossman D, Torgerson T, Graham P, Prasad V, Knutsen A, Chong H, Miller H, de la Morena MT, DeSantes K, Cowan MJ, Notarangelo LD, Kohn DB, Stenger E, Pai SY, Routes JM, Puck JM, Kapoor N, Pulsipher MA, Malech HL, Parikh S, Kang EM, submitted on behalf of the Primary Immune Deficiency Treatment Consortium (2019). Chronic Granulomatous Disease-Associated IBD Resolves and Does Not Adversely Impact Survival Following Allogeneic HCT. J Clin Immunol, 39(7), 653-667.
- Li C, Liu T, Liu B, Hernandez R, Facelli JC, Grossman D (2019). A novel CDKN2A variant (p16L117P ) in a patient with familial and multiple primary melanomas. Pigment Cell Melanoma Res, 32(5), 734-738.
- Wu YP, Parsons BG, Aspinwall LG, Hay JL, Boucher KM, Caputo H, Mooney R, Grossman D, Leachman SA (2019). Parent and child perspectives on perceived barriers to child sun protection and their association with sun protection strategies among children of melanoma survivors. Pediatr Dermatol, 36(3), 317-323.
- Gardner LJ, Strunck JL, Wu YP, Grossman D (2018). Current controversies in early-stage melanoma: Questions on incidence, screening, and histologic regression. J Am Acad Dermatol, 80(1), 1-12.
- Klapperich ME, Bowen GM, Grossman D (2018). Current controversies in early-stage melanoma: Questions on management and surveillance. J Am Acad Dermatol, 80(1), 15-25.
- Goodson AG, Florell SR, Boucher KM, Grossman D (2011). A decade of melanomas: identification of factors associated with delayed detection in an academic group practice. Dermatol Surg, 37(11), 1620-30.
- McKenzie JA, Liu T, Goodson AG, Grossman D (2010). Survivin enhances motility of melanoma cells by supporting Akt activation and {alpha}5 integrin upregulation. Cancer Res, 70(20), 7927-37.
- Goodson AG, Florell SR, Hyde M, Bowen GM, Grossman D (2010). Comparative analysis of total body and dermatoscopic photographic monitoring of nevi in similar patient populations at risk for cutaneous melanoma. Dermatol Surg, 36(7), 1087-98.
- Goodson AG, Cotter MA, Cassidy P, Wade M, Florell SR, Liu T, Boucher KM, Grossman D (2009). Use of oral N-acetylcysteine for protection of melanocytic nevi against UV-induced oxidative stress: towards a novel paradigm for melanoma chemoprevention. Clin Cancer Res, 15(23), 7434-40.
Case Report
Letter
- Grossman D, Sweeney C, Doherty JA (2021). The Rapid Rise in Cutaneous Melanoma Diagnoses. [Letter to the editor]. N Engl J Med, 384(14), e54.
- Grossman D, Florell SR, Duffy KL, Bowen GM (2019). Histologic criteria for assessing surgical margins in melanoma in situ. [Letter to the editor]. J Am Acad Dermatol, 82(4), e133-e134.
- Varedi A, Gardner LJ, Kim CC, Chu EY, Ming ME, Leachman SA, Curiel-Lewandrowski C, Swetter SM, Grossman D (2019). Use of new molecular tests for melanoma by pigmented-lesion experts. [Letter to the editor]. J Am Acad Dermatol, 82(1), 245-247.
- Varedi A, Bishop MD, Boucher KM, Kim CC, Grossman D (2019). Powering a prospective melanoma chemoprevention trial in high-risk cohorts. [Letter to the editor]. Int J Dermatol, 58(11), e232-e234.
Patent
- Grossman D (2008). Use of N-acetylcysteine for inhibition of UV-induced skin cancer. U.S. Patent No. Ref. No. 083404-0153, international PCT US08/62893; U.S. Provisional Patent No. 60/916703. Washington, D.C.:U.S. Patent and Trademark Office.
- Grossman D (2007). Use of N-acetylcystein for chemoprevention of UV-induced melanoma, University of Utah Technology Commercialization Office.
- Grossman D, Yan H (2006). A cell-permeable (TAT) Survivin antagonist to treat melanoma.